Inclusion of heterozygotes for cystic fibrosis in the egg donor pool

Fertility and Sterility

Volumn 78, Issue 3, 2002, Pages 557-561

  Zenke, Ulrike ^a   Chetkowski, Ryszard J ^a  

^a NONE   (United States)

Author keywords

Carrier testing; Cystic fibrosis; Gamete donors; Genetic screening; Oocyte donation; Residual risk

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; FAMILY HISTORY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HETEROZYGOSITY; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMAN; HUMAN CELL; MALE; OOCYTE DONATION; OOCYTE DONOR; PRIORITY JOURNAL; RECIPIENT; RISK ASSESSMENT;

CALIFORNIA; CYSTIC FIBROSIS; ETHNIC GROUPS; FEMALE; HETEROZYGOTE DETECTION; HUMANS; MUTATION; OOCYTE DONATION; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0036732232     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03248-X     Document Type: Article

References (14)

1. Cystic fibrosis in infertility; screening before assisted reproduction
2. Cystic fibrosis and the National Institutes of Health consensus statement; are obstetrician-gynecologists ready to comply?
3. Genetic testing for cystic fibrosis
4. Survey of genetic screening for oocyte donors
5. Ethical considerations of the new reproductive technologies; appendix B: minimal genetic screen for gamete donors
6. Genetic screening of gamete donors
7. Guidelines for gamete and embryo donation; appendix A: minimal genetic screening for gamete donors
8. Genetic screening of prospective oocyte donors
9. Cystic fibrosis Delta F508 heterozygotes, smoking, and reproduction; studies of 9141 individuals from a general population sample
10. Perception of risk
11. Health and safety risk analyses; information for better decisions
12. A test of the heterozygote-advantage hypothesis in cystic fibrosis carrier
13. Hypothesis; a selective advantage for cystic fibrosis heterozygotes